🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

144,67 USD

Máx. histórico

156,45

70 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-7,53%

Rango 52 semanas

82,01 – 156,92

Variación hoy

-2,49%

Cierre anterior

148,36

Rango de hoy

143,47 – 147,62

Volumen hoy

8.862.415

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,42%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
146,13 (puede no estar actualizado)
Dividend yield
2,29% (puede no estar actualizado)
Precio objetivo analistas
160,29 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 9 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,35%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
06/11/2023 104,08 104,37 103,14 104,34 +0,93% 1,18% 5.951.200
03/11/2023 103,37 104,25 102,78 103,38 +0,52% 1,42% 6.005.900
02/11/2023 102,74 103,06 101,65 102,85 +0,00% 1,37% 5.379.100
01/11/2023 103,55 104,23 102,73 102,85 +0,15% 1,45% 5.838.100
31/10/2023 102,77 103,55 101,40 102,70 +0,02% 2,09% 7.522.600
30/10/2023 103,28 104,50 102,61 102,68 -0,14% 1,83% 6.915.500
27/10/2023 105,32 105,57 102,22 102,82 -2,59% 3,18% 8.933.800
26/10/2023 103,10 107,23 102,99 105,55 +1,85% 4,11% 11.335.700
25/10/2023 103,35 104,61 102,95 103,63 +0,58% 1,61% 7.849.200
24/10/2023 103,32 104,06 102,68 103,03 -0,31% 1,34% 6.347.900
23/10/2023 102,83 104,15 102,67 103,35 +0,66% 1,44% 8.493.000
20/10/2023 99,99 103,36 99,99 102,67 +2,23% 3,37% 12.467.500
19/10/2023 101,66 101,73 99,14 100,43 -1,53% 2,55% 7.647.600
18/10/2023 104,11 104,46 101,91 101,99 -2,09% 2,45% 7.136.400
17/10/2023 104,00 104,49 103,15 104,17 +0,03% 1,29% 5.827.200
16/10/2023 104,20 105,37 104,06 104,14 +0,12% 1,26% 6.473.500
13/10/2023 103,61 104,52 102,78 104,01 +0,41% 1,68% 5.787.500
12/10/2023 103,52 103,95 102,93 103,59 +0,13% 0,99% 5.124.000
11/10/2023 104,00 104,21 102,85 103,46 -0,14% 1,31% 5.375.100
10/10/2023 104,32 104,46 103,16 103,61 -0,85% 1,25% 7.177.200
09/10/2023 103,50 105,19 103,31 104,50 +0,60% 1,82% 5.061.100
06/10/2023 103,73 104,43 102,92 103,88 +0,27% 1,46% 6.854.900
05/10/2023 102,36 103,71 102,34 103,60 +1,40% 1,34% 6.449.100
04/10/2023 101,58 102,43 101,33 102,17 +0,39% 1,08% 6.720.500
03/10/2023 102,24 102,44 100,92 101,77 -0,76% 1,49% 5.924.000
02/10/2023 102,83 102,83 101,35 102,55 -0,39% 1,44% 7.079.700
29/09/2023 104,36 104,68 102,71 102,95 -1,29% 1,89% 7.232.700
28/09/2023 104,57 104,97 103,78 104,30 +0,35% 1,14% 4.758.800
27/09/2023 105,45 105,52 103,30 103,94 -1,38% 2,11% 5.635.500
26/09/2023 105,12 106,55 105,11 105,39 -0,43% 1,37% 5.400.500